SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001023024-08-000009
Filing Date
2008-05-09
Accepted
2008-05-09 16:59:28
Documents
5
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 BIOSANTE 10Q FIRST QUARTER 2008 biosante10qq12008.htm 10-Q 540982
2 CEO SECTION 302 exhibit31w1.htm EX-31.1 10493
3 CFO SECTION 302 exhibit31w2.htm EX-31.2 11396
4 CEO SECTION 906 exhibit32w1.htm EX-32.1 4377
5 CFO SECTION 906 exhibit32w2.htm EX-32.2 4666
  Complete submission text file 0001023024-08-000009.txt   573443
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 08819415
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences